• Explore /
  • Poster
  • / Lisavanbulin in patients with recurrent glioblastoma: Phase 2a results and a consolidated analysis of response-predictive biomarkers.

Lisavanbulin in patients with recurrent glioblastoma: Phase 2a results and a consolidated analysis of response-predictive biomarkers.

Abstract Poster

Authors

null

Juanita Suzanne Lopez

The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

Juanita Suzanne Lopez , Simon Haefliger , Ruth Plummer , Paul M. Clement , Heinz Philipp Laubli , Patrick Roth , T.R. Jeffry Evans , Lucy Brazil , Ghazaleh Tabatabai , Antje Wick , Wing Hing Hing Yau , Benjamin Wunderlich , Kirk Beebe , Joel Robert Eisner , Marc Engelhardt , Thomas Kaindl , Heidi A Lane , Peter Hau , Thomas Hundsberger , Joachim Steinbach

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Primary CNS Tumors–Glioma

Clinical Trial Registration Number

NCT02490800

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 2044)

DOI

10.1200/JCO.2023.41.16_suppl.2044

Abstract #

2044

Poster Bd #

401

Abstract Disclosures

Similar Posters

First Author: Crescens Diane Tiu

First Author: Magdalena Skowronska

First Author: Patrick Y. Wen

Poster

2022 ASCO Annual Meeting

Identifying biomarkers associated with disease-free survival in stage I non–small cell lung cancer.

Identifying biomarkers associated with disease-free survival in stage I non–small cell lung cancer.

First Author: Christopher W. Seder